Overview

Drug to Drug Interaction Study With Ipragliflozin and Furosemide

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
A study to investigate if there are any pharmacodynamic and pharmacokinetic interactions between furosemide and ipragliflozin (ASP1941) in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Europe B.V.
Treatments:
Furosemide
Ipragliflozin